Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision

免疫疗法 癌症 癌症免疫疗法 医学 内科学
作者
Leisha A. Emens,Pedro Romero,Ana C. Anderson,Tullia C. Bruno,Christian M. Capitini,Deborah Collyar,James L. Gulley,Patrick Hwu,Avery D. Posey,Ann W. Silk,Jennifer A. Wargo
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:12 (6): e009063-e009063 被引量:3
标识
DOI:10.1136/jitc-2024-009063
摘要

Cancer immunotherapy has flourished over the last 10–15 years, transforming the practice of oncology and providing long-term clinical benefit to some patients. During this time, three distinct classes of immune checkpoint inhibitors, chimeric antigen receptor-T cell therapies specific for two targets, and two distinct classes of bispecific T cell engagers, a vaccine, and an oncolytic virus have joined cytokines as a standard of cancer care. At the same time, scientific progress has delivered vast amounts of new knowledge. For example, advances in technologies such as single-cell sequencing and spatial transcriptomics have provided deep insights into the immunobiology of the tumor microenvironment. With this rapid clinical and scientific progress, the field of cancer immunotherapy is currently at a critical inflection point, with potential for exponential growth over the next decade. Recognizing this, the Society for Immunotherapy of Cancer convened a diverse group of experts in cancer immunotherapy representing academia, the pharmaceutical and biotechnology industries, patient advocacy, and the regulatory community to identify current opportunities and challenges with the goal of prioritizing areas with the highest potential for clinical impact. The consensus group identified seven high-priority areas of current opportunity for the field: mechanisms of antitumor activity and toxicity; mechanisms of drug resistance; biomarkers and biospecimens; unique aspects of novel therapeutics; host and environmental interactions; premalignant immunity, immune interception, and immunoprevention; and clinical trial design, endpoints, and conduct. Additionally, potential roadblocks to progress were discussed, and several topics were identified as cross-cutting tools for optimization, each with potential to impact multiple scientific priority areas. These cross-cutting tools include preclinical models, data curation and sharing, biopsies and biospecimens, diversification of funding sources, definitions and standards, and patient engagement. Finally, three key guiding principles were identified that will both optimize and maximize progress in the field. These include engaging the patient community; cultivating diversity, equity, inclusion, and accessibility; and leveraging the power of artificial intelligence to accelerate progress. Here, we present the outcomes of these discussions as a strategic vision to galvanize the field for the next decade of exponential progress in cancer immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马甲应助向7看齐采纳,获得10
刚刚
脑洞疼应助坚定的学姐采纳,获得20
1秒前
xtt完成签到,获得积分10
3秒前
4秒前
5秒前
小柒发布了新的文献求助10
5秒前
7秒前
123发布了新的文献求助10
7秒前
山茶完成签到 ,获得积分20
9秒前
9秒前
9秒前
10秒前
10秒前
小二郎应助淡定从霜采纳,获得10
10秒前
away发布了新的文献求助10
11秒前
mm发布了新的文献求助10
11秒前
Ck发布了新的文献求助10
11秒前
勤奋以蓝完成签到,获得积分20
13秒前
Crystal完成签到 ,获得积分10
13秒前
追风少年应助张佳明采纳,获得10
14秒前
14秒前
归海浩阑完成签到,获得积分10
14秒前
俭朴千万发布了新的文献求助10
15秒前
16秒前
16秒前
dddd发布了新的文献求助10
16秒前
天天快乐应助哭泣的靳采纳,获得10
17秒前
swimvan完成签到,获得积分10
18秒前
zheli完成签到,获得积分10
19秒前
共享精神应助零九采纳,获得10
20秒前
黑椒HJ发布了新的文献求助10
20秒前
20秒前
我是老大应助like1994采纳,获得10
21秒前
小马甲应助俞思含采纳,获得10
22秒前
23秒前
一匹野马发布了新的文献求助10
24秒前
Miss完成签到 ,获得积分20
25秒前
29秒前
充电宝应助雨中过客采纳,获得10
29秒前
情怀应助自由青柏采纳,获得10
29秒前
高分求助中
Lire en communiste 1000
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Becoming: An Introduction to Jung's Concept of Individuation 600
Evolution 3rd edition 500
Die Gottesanbeterin: Mantis religiosa: 656 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3171230
求助须知:如何正确求助?哪些是违规求助? 2822135
关于积分的说明 7938200
捐赠科研通 2482633
什么是DOI,文献DOI怎么找? 1322678
科研通“疑难数据库(出版商)”最低求助积分说明 633676
版权声明 602627